Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hamlet BioPharma AB (publ) | HAMLETB | Apr 23, 2024 | 2.24 | -0.44 |
Hansa Biopharma | HNSA | Apr 23, 2024 | 27.96 | -0.64 |
Hanza AB | HANZA | Apr 23, 2024 | 59.80 | +1.79 |
Harm Reduction Group | NOHARM | Apr 23, 2024 | 0.12 | -1.23 |
Havsfrun Investment | HAVS | Apr 23, 2024 | 13.40 | -1.47 |
Havsfrun Investment B | HAVB | Apr 23, 2024 | 13.40 | -1.47 |
Haypp Group | HAYPP | Apr 23, 2024 | 78.80 | +1.03 |
Headsent | VIMAB | Apr 23, 2024 | 10.30 | +2.49 |
Heba B | HEBAB | Apr 23, 2024 | 33.25 | +1.84 |
Hedera Group | HEGR | Apr 23, 2024 | 6.00 | +2.56 |
Heimstaden Pref | HEIMPREF | Apr 23, 2024 | 8.74 | +1.63 |
Heliospectra | HELIO | Apr 23, 2024 | 0.40 | 0.00 |
Hemnet Group | HEM | Apr 23, 2024 | 299.40 | -3.79 |
Hemply Balance | HMPLY | Apr 23, 2024 | 0.04 | 0.00 |
Hexagon B | HEXAB | Apr 23, 2024 | 122.90 | +1.95 |
Hexagon Purus | HPURO | Apr 23, 2024 | 4.84 | -2.72 |
Hexatronic Group | HTRO | Apr 23, 2024 | 31.72 | +3.52 |
Hexicon | HEXI | Apr 23, 2024 | 0.56 | +7.47 |
Hexpol B | HPOLB | Apr 23, 2024 | 131.00 | +1.39 |
Hifab B | HIFAB | Apr 23, 2024 | 2.40 | 0.00 |
High Coast Distillery B | HIGHCOB | Apr 23, 2024 | 45.60 | -0.44 |
Hilbert | HILBB | Apr 23, 2024 | 4.26 | +0.24 |
HMS Networks | HMS | Apr 23, 2024 | 427.00 | +0.99 |
Hoegh Autoliners ASA | HAUTOO | Apr 23, 2024 | 99.65 | +2.00 |
Hoi Publishing AB | HOIB | Apr 23, 2024 | 0.43 | +9.14 |
Hoist Finance | HOFI | Apr 23, 2024 | 52.40 | +1.95 |
Holmen A | HOLMA | Apr 23, 2024 | 417.00 | -0.24 |
Holmen B | HOLMB | Apr 23, 2024 | 418.00 | -0.43 |
HomeMaid B | HOMEB | Apr 23, 2024 | 14.70 | 0.00 |
Hoodin | HOODIN | Apr 23, 2024 | 0.23 | -42.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.